TABLE 1.
Targeta | Primer pair sequences |
---|---|
ADH1 (A) | 5′-CTACACCAATTACACTGCCTCATT-3′, 5′-ACTTCAATAGATGGCAAATGGA-3′ |
ADH1 (B) | 5′-GGTATACGGCCTTCCTTCCAGTTAC-3′, 5′-GAACGAGAACAATGACGAGGAAACAAAAG-3′ |
ADH1 (C) | 5′-CTGCACAATATTTCAAGCTATACCAAGC-3′, 5′-GCCTTTGGCTTTGGAACTGGAATATC-3′ |
ADH1 (D) | 5′-GATATTCCAGTTCCAAAGCCAAAGGC-3′, 5′-CTTAACTGGCAATGGCCAGTCAC-3′ |
ADH1 (E) | 5′-CGGTAACAGAGCTGACACCAGAGA-3′, 5′-ACGTATCTACCAACGATTTGACCC-3′ |
ADH1 (F) | 5′-GATATTCCAGTTCCAAAGCCAAAGGC-3′, 5′-CTTAACTGGCAATGGCCAGTCAC-3′ |
ADH1 (G) | 5′-CTGGTTACACCCACGACGGTTCTT-3′, 5′-GCAGACTTCAAAGCCTTGTAGACG-3′ |
ADHI (H) | 5′-CGGTAACAGAGCTGACACCAGAGA-3′, 5′-ACGTATCTACCAACGATTTGACCC-3′ |
PYK1 (5′ ORF) | 5′-CTTGTTTCTATTTACAAGACACCAATC-3′, 5′-CTTTGGACCGATGGTACCAATG-3′ |
PYK1 (ORF or 3′ ORF) | 5′-AAGTTTCCGATGTCGGTAACGCTAT-3′, 5′-TTGGCAAGTAAGCGATAGCTTGTTC-3′ |
PGK1 (5′ ORF) | 5′-CAGATCATCAAGGAAGTAATTATC-3′, 5′-GTCAACTCTGATGAAGACACGC-3′ |
PGK1 (ORF or 3′ ORF) | 5′-AGACGAAGTTGTCAAGAGCTCTGC-3′, 5′-GAAAGCAACACCTGGCAATTCCT-3′ |
PMA1 (A) | 5′-TCGATGGTGGGTACCGCTTAT-3′, 5′-GATGTTAGACGATAATGATAGGAC-3′ |
PMA1 (B or 5′ ORF) | 5′-ATCTTCTGACGATGACGATATCG-3′, 5′-TTCTGGAACTGGTCTAGCTTCA-3′ |
PMA1 (C or 3′ ORF) | 5′-TCGGTGCTATGAACGGTATTATG-3′, 5′-ACATGGTAGCGATGATGTCGACAG-3′ |
GAL1 (UAS) | 5′-CGCTTAACTGCTCATTGCTATATTG-3′, 5′-TTGTTCGGAGCAGTGCGGCGC-3′ |
GAL1 (Core) | 5′-ATAGGATGATAATGCGATTAGTTTTTTAGCCTT-3′, 5′-GAAAATGTTGAAAGTATTAGTTAAAGTGGTTATGCA-3′ |
GAL1 (promoter-proximal site) | 5′-ACCTCTATACTTTAACGTCAAGGAG-3′, 5′-TTTCGGCCAATGGTCTTGGTAA-3′ |
GAL1 (ORF1) | 5′-GTGAGGAAGATCATGCTCTATACG-3′, 5′-GGCGGTTTCAAACTTGTTAGATAC-3′ |
GAL1 (ORF2) | 5′-CAGAGGGCTAAGCATGTGTATTCT-3′, 5′-GTCAATCTCTGGACAAGAACATTC-3′ |
Chr V | 5′-GGCTGTCAGAATATGGGGCCGTAGTA-3′, 5′-CACCCCGAAGCTGCTTTCACAATAC-3′ |
UAS, upstream activating sequence; Core, core promoter; ORF1 and ORF2, two different locations in the ORF; 5′ ORF, toward the 5′ end of the ORF; 3′ ORF, toward the 3′ end of the ORF. Different locations at a genomic locus are designated by different letters.